Literature DB >> 28681977

Detection and quantification of Merkel cell polyomavirus. Analysis of Merkel cell carcinoma cases from 1977 to 2015.

Marta E Álvarez-Argüelles1, Santiago Melón1, Susana Rojo1, Ana Fernandez-Blázquez1, Jose A Boga1, Ana Palacio1, Blanca Vivanco2, María de Oña1.   

Abstract

This study investigates the presence of Merkel cell polyomavirus (MCPyV) in skin lesions of patients with Merkel cell carcinoma (MCC). MCPyV was quantified using quantitative Real-Time-PCR (qRT-PCR) in 34 paraffinized MCC samples (resected/biopsied) originally taken between 1977 and 2015, and six non-MCC samples. In 31 (91.2%) MCC-individuals, MCPyV was detected. No virus was observed in any non-MCC tumor. Average age at diagnosis was 78.2 ± 9.35 (55-97) years for women (n = 19) and 69.5 ± 14.7 (45-91) for men (n = 15) (P = 0.04). MCC tumor location, known in 25 cases, was: 11 (44%) in the head region, 6 (24%) in upper limbs, 4 (16%) in lower limbs, and 4 (16%) in the trunk. All but one patient had received some sort of treatment: 15 (45.45%) underwent both radio and chemotherapy, 13 (39.39%) only surgery, 2 (6.06%) surgery, plus radio and chemotherapy, 2 (6.06%) surgery and chemotherapy, and 1 (3.03%) only radiotherapy. Follow up data were available for 21/34 patients: recurrence was recorded for 4 (19.04%), and metastasis for 13 (61.9%). Recorded data showed that 10 men and 5 women (total 44.1%) died during follow up, 7 (46.7%) of them within 2 years of diagnosis. Viral load was 5.8 ± 1.4 log copies/105 cells (3.1-8.6), independent of any variable. MCPyV was very frequent in MCC. It was principally associated with head and limb tumors, it more commonly affected men, who in this study were, on average, younger than women, and had high rates of recurrence and mortality. The amplification techniques described here are easily applied and suitable for detecting the presence of MCPyV virus in MCC.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  neuroendocrine cancer; quantitative Real-Time-PCR; skin lesions; viral load

Mesh:

Substances:

Year:  2017        PMID: 28681977     DOI: 10.1002/jmv.24896

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  HLA-G expression in Merkel cell carcinoma and the correlation with Merkel cell polyomavirus infection.

Authors:  L M Parra; B G C Sartori; D R Fernandes; L R V Fachin; M R S Nogueira; A F F Belone; A J F Nunes; F C Souza-Santana
Journal:  Immunogenetics       Date:  2022-10-14       Impact factor: 3.330

Review 2.  Merkel Cell Polyoma Virus and Cutaneous Human Papillomavirus Types in Skin Cancers: Optimal Detection Assays, Pathogenic Mechanisms, and Therapeutic Vaccination.

Authors:  Ramona Gabriela Ursu; Costin Damian; Elena Porumb-Andrese; Nicolae Ghetu; Roxana Gabriela Cobzaru; Catalina Lunca; Carmen Ripa; Diana Costin; Igor Jelihovschi; Florin Dumitru Petrariu; Luminita Smaranda Iancu
Journal:  Pathogens       Date:  2022-04-16

Review 3.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

Review 4.  The Role of miRNAs in Virus-Mediated Oncogenesis.

Authors:  Zuzana Vojtechova; Ruth Tachezy
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

5.  Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma.

Authors:  Jens von der Grün; Ria Winkelmann; Markus Meissner; Ulrike Wieland; Steffi Silling; Daniel Martin; Emmanouil Fokas; Claus Rödel; Franz Rödel; Panagiotis Balermpas
Journal:  Front Oncol       Date:  2019-01-24       Impact factor: 6.244

6.  Prevalence of Merkel Cell Polyomavirus in Normal and Lesional Skin: A Systematic Review and Meta-Analysis.

Authors:  Wilson A Wijaya; Yu Liu; Yong Qing; Zhengyong Li
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.